{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:27:08Z","timestamp":1790116028789,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejso.2024.107955","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T11:33:38Z","timestamp":1704540818000},"page":"107955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Eliminating the need for preoperative intravenous hyperhydration: Sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients \u2013 A retrospective analysis"],"prefix":"10.1016","volume":"50","author":[{"given":"Elea","family":"Vachez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7951-4041","authenticated-orcid":false,"given":"Amaniel","family":"Kefleyesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoual","family":"Bakrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-4231","authenticated-orcid":false,"given":"Florence","family":"Ranchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rioufol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Vassal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Al-Hadeedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9885-8600","authenticated-orcid":false,"given":"Vahan","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.ejso.2024.107955_bib1","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1002\/cncr.25356","article-title":"Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1290 patients","volume":"116","author":"Glehen","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2024.107955_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ejso.2024.107955_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1245\/ASO.2003.08.006","article-title":"Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia","volume":"10","author":"Mohamed","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.107955_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-12-526","article-title":"Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials","volume":"12","author":"Sun","year":"2012","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2024.107955_bib5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/IGC.0b013e3181a83f7e","article-title":"Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of recurrent endometrial carcinoma confined to the peritoneal cavity","volume":"20","author":"Bakrin","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"36","key":"10.1016\/j.ejso.2024.107955_bib6","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.107955_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejso.2020.02.012","article-title":"Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment","volume":"47","author":"Govaerts","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2024.107955_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.suronc.2018.05.025","article-title":"Nephrotoxicity and long-term survival investigations for patients with peritoneal carcinomatosis using hyperthermic intraperitoneal chemotherapy with cisplatin: a retrospective cohort study","volume":"27","author":"Ye","year":"2018","journal-title":"Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2024.107955_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1634\/theoncologist.2016-0319","article-title":"A\u00a0systematic review of strategies to prevent cisplatin-induced nephrotoxicity","volume":"22","author":"Crona","year":"2017","journal-title":"Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.107955_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/02656736.2020.1795277","article-title":"Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin","volume":"37","author":"Laplace","year":"2020","journal-title":"Int J Hyperther"},{"issue":"9","key":"10.1016\/j.ejso.2024.107955_bib11","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1245\/s10434-007-9429-1","article-title":"Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity","volume":"14","author":"Kusamura","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.107955_bib12","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/02656736.2017.1293304","article-title":"Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy","volume":"33","author":"Sin","year":"2017","journal-title":"Int J Hyperther"},{"issue":"20","key":"10.1016\/j.ejso.2024.107955_bib13","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.107955_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00694330","article-title":"Cisplatin nephrotoxicity - a review","volume":"25","author":"Daugaard","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1016\/j.ejso.2024.107955_bib15","first-page":"13","article-title":"Renal excretion kinetics of high-dose cis-dichlorodiammineplatinum(II) administered with hydration and mannitol diuresis","volume":"63","author":"Frick","year":"1979","journal-title":"Cancer Treat Rep"},{"issue":"3","key":"10.1016\/j.ejso.2024.107955_bib16","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1124\/jpet.105.087601","article-title":"Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in\u00a0vivo levels","volume":"314","author":"Dickey","year":"2005","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"issue":"25","key":"10.1016\/j.ejso.2024.107955_bib17","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium thiosulfate for protection from cisplatin-induced hearing loss","volume":"378","author":"Brock","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2024.107955_bib18","article-title":"Sodium thiosulfate for postoperative cisplatin induced nephrotoxicity following hyperthermic intraperitoneal chemotherapy: a case report","volume":"36","author":"Patel","year":"2021","journal-title":"Gynecol Oncol Rep"},{"issue":"6","key":"10.1016\/j.ejso.2024.107955_bib19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.annemergmed.2006.09.021","article-title":"Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning?","volume":"49","author":"Hall","year":"2007","journal-title":"Ann Emerg Med"},{"issue":"12","key":"10.1016\/j.ejso.2024.107955_bib20","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1023\/A:1008296202198","article-title":"Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease","volume":"8","author":"Van Rijswijk","year":"1997","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.107955_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0959-8049(05)80017-6","article-title":"Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy-a phase II study of the EORTC gynaecological cancer cooperative group","volume":"30","author":"Guastalla","year":"1994","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2024.107955_bib22","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1245\/s10434-021-10490-4","article-title":"Time to evolve terminology from \u201cdebulking\u201d to cytoreductive surgery (CRS) in ovarian cancer","volume":"28","author":"Brennan","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.107955_bib23","first-page":"359","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"15","author":"Jacquet","year":"1996","journal-title":"J\u00a0Exp Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.ejso.2024.107955_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ejso.2024.107955_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2024.107955_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4251\/wjgo.v2.i2.68","article-title":"Hyperthermic intraperitoneal chemotherapy: rationale and technique","volume":"2","author":"Gonz\u00e1lez-Moreno","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2024.107955_bib27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamasurg.2022.0143","article-title":"Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial","volume":"157","author":"Lim","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2024.107955_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.809773","article-title":"Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery in ovarian cancer: an umbrella review of meta-analyses","volume":"12","author":"Souadka","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.107955_bib29","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1245\/s10434-021-11087-7","article-title":"Cytoreductive surgery with or without HIPEC after neoadjuvant chemotherapy in ovarian cancer: a phase 3 clinical trial","volume":"29","author":"Antonio","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.107955_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejso.2020.02.011","article-title":"Peritoneal mesothelioma: PSOGI\/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"47","author":"Kusamura","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.107955_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejso.2020.02.012","article-title":"Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment","volume":"47","author":"Govaerts","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2024.107955_bib32","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.ejso.2021.05.016","article-title":"Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: a meta-analysis of randomized controlled trials","volume":"47","author":"Granieri","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2024.107955_bib33","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3390\/medicina59071306","article-title":"Sodium thiosulfate for calciphylaxis treatment in patients on peritoneal dialysis: a systematic review","volume":"59","author":"Gossett","year":"2023","journal-title":"Medicina"},{"issue":"4","key":"10.1016\/j.ejso.2024.107955_bib34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/j.1552-4604.1992.tb03849.x","article-title":"The antidotal action of sodium nitrite and sodium thiosulfate against cyanide poisoning","volume":"32","author":"Baskin","year":"1992","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.ejso.2024.107955_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0090-8258(91)90081-F","article-title":"Neutralizing effect of sodium thiosulfate on antitumor efficacy of cisplatin for human carcinoma xenografts in nude mice","volume":"40","author":"Inoue","year":"1991","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.107955_bib36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1158\/1078-0432.CCR-06-2289","article-title":"Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity","volume":"14","author":"Harned","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"16_suppl","key":"10.1016\/j.ejso.2024.107955_bib37","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.5510","article-title":"Hyperthermic intraperitoneal chemotherapy in platinum-sensitive relapsed epithelial ovarian cancer: the CHIPOR randomized phase III trial","volume":"41","author":"Classe","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.107955_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00280-003-0620-1","article-title":"Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial","volume":"52","author":"Santoso","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"10.1016\/j.ejso.2024.107955_bib39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.sla.0000094387.50865.23","article-title":"Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens - a randomized assessor-blinded multicenter trial","volume":"238","author":"Brandstrup","year":"2003","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2024.107955_bib40","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/01.sla.0000143269.96649.3b","article-title":"Liberal versus restrictive fluid administration to improve recovery after laparoscopic cholecystectomy: a randomized, double-blind study","volume":"240","author":"Holte","year":"2004","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2024.107955_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bpa.2005.10.007","article-title":"Fluid therapy for the surgical patient","volume":"20","author":"Brandstrup","year":"2006","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"3","key":"10.1016\/j.ejso.2024.107955_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000187208","article-title":"Comparison of fine-needle aspiration biopsy, Doppler ultrasound, and radionuclide scintigraphy in the diagnosis of acute allograft dysfunction in renal transplant recipients: sensitivity, specificity, and cost analysis","volume":"63","author":"Delaney","year":"1993","journal-title":"Nephron"},{"issue":"5\u20136","key":"10.1016\/j.ejso.2024.107955_bib43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.clinbiochem.2006.10.026","article-title":"Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis","volume":"40","author":"Roos","year":"2007","journal-title":"Clin Biochem"},{"issue":"12","key":"10.1016\/j.ejso.2024.107955_bib44","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.ejso.2020.08.006","volume":"46","author":"H\u00fcbner","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2024.107955_bib45","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ejso.2020.07.041","article-title":"Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) society recommendations \u2014 Part I: preoperative and intraoperative management","volume":"46","author":"H\u00fcbner","year":"2020","journal-title":"Eur J Surg Oncol"}],"updated-by":[{"DOI":"10.1016\/j.ejso.2025.109651","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000}}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T16:51:54Z","timestamp":1708793514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0748798324000076"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.107955","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eliminating the need for preoperative intravenous hyperhydration: Sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients \u2013 A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.107955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107955"}}